Form 4 for OPRX OptimizeRx Corp
Accepted 2026-09-02 15:20:09 ET · period of report 2026-09-01 · accession 0001628280-26-060059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 15:20 | 2026-09-01 | OPRX | D'Silva Andrew J. | Chief Business Off | F - Tax | $7.86 | -1,432 | 99.7K | -1% | -$11.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | F | D | 1,432 | $7.86 | 99,660 | D | — | — | (F1) These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. |